BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22211288)

  • 21. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987.
    Knowles DM; Jakobiec FA; McNally L; Burke JS
    Hum Pathol; 1990 Sep; 21(9):959-73. PubMed ID: 2394438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular adnexal lymphoid proliferations: clinical, histologic, flow cytometric, and molecular analysis of forty-three cases.
    Sharara N; Holden JT; Wojno TH; Feinberg AS; Grossniklaus HE
    Ophthalmology; 2003 Jun; 110(6):1245-54. PubMed ID: 12799255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular adnexal lymphoma-comparison of MALT lymphoma with other histological types.
    Cahill M; Barnes C; Moriarty P; Daly P; Kennedy S
    Br J Ophthalmol; 1999 Jun; 83(6):742-7. PubMed ID: 10340987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical analysis of ocular adnexal mucosa-associated lymphoid tissue lymphoma with IgG4-related ophthalmic disease.
    Yoon J; Kim KJ; Sa HS
    Orbit; 2022 Oct; 41(5):551-557. PubMed ID: 34369286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCL10 expression in ocular adnexal lymphomas.
    Vejabhuti C; Harris GJ; Erickson BA; Nishino H; Chevez-Barrios P; Chang CC
    Am J Ophthalmol; 2005 Nov; 140(5):836-843. PubMed ID: 16310461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphoproliferative lesions of the lacrimal gland: clinicopathological, immunohistochemical and molecular genetic analysis.
    Farmer JP; Lamba M; Lamba WR; Jordan DR; Gilberg S; Sengar DP; Bence-Bruckler I; Burns BF
    Can J Ophthalmol; 2005 Apr; 40(2):151-60. PubMed ID: 16049528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating breast lymphoplasmacytic infiltrates: a multiparameter immunohistochemical study, including assessment of IgG4.
    Berg AN; Soma L; Clark BZ; Swerdlow SH; Roth CG
    Hum Pathol; 2015 Aug; 46(8):1162-70. PubMed ID: 26026200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia.
    Mannami T; Yoshino T; Oshima K; Takase S; Kondo E; Ohara N; Nakagawa H; Ohtsuki H; Harada M; Akagi T
    Mod Pathol; 2001 Jul; 14(7):641-9. PubMed ID: 11454995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prevalence study of IgG4-related ophthalmic disease in Japan.
    Japanese study group of IgG4-related ophthalmic disease
    Jpn J Ophthalmol; 2013 Nov; 57(6):573-9. PubMed ID: 23917985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synchronous pulmonary and lachrymal glands involvement by MALT lymphoma].
    Batti R; Letaief F; Rachdi H; Zidi A; Sghaier S; Ayadi M; Meddeb K; Mokrani A; Yahyaoui Y; Raies H; Chraiet N; Mezlini A
    Pan Afr Med J; 2018; 29():198. PubMed ID: 30061976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory pseudotumor of eyelid: a probable IgG4-related sclerosing disease clinically mimicking eyelid pilomatrixoma.
    Choi YJ; Lee MJ; Kim N; Choung HK; Khwarg SI; Kim JE
    BMC Ophthalmol; 2015 Mar; 15():23. PubMed ID: 25880568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CT and MR imaging findings of ocular adnexal mucosa-associated lymphoid tissue lymphoma associated with IgG4-related disease: multi-institutional case series.
    Yoo RE; Park SW; Rhim JH; Kim JE; Kim SC; Choe JY; Choung HK; Khwarg SI; Kim JH; Lee JH; Lee BE; Kang Y
    Int J Ophthalmol; 2020; 13(8):1231-1237. PubMed ID: 32821676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A subset of ocular adnexal marginal zone lymphomas may arise in association with IgG4-related disease.
    Ohno K; Sato Y; Ohshima K; Takata K; Miyata-Takata T; Takeuchi M; Gion Y; Tachibana T; Orita Y; Ito T; Swerdlow SH; Yoshino T
    Sci Rep; 2015 Aug; 5():13539. PubMed ID: 26311608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG4-positive extranodal marginal zone lymphoma arising in Hashimoto's thyroiditis: clinicopathological and cytogenetic features of a hitherto undescribed condition.
    Tan CL; Ong YK; Tan SY; Ng SB
    Histopathology; 2016 May; 68(6):931-7. PubMed ID: 26332259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland: A case report and literature review.
    Zhong Q; Yan Y; Li S
    Medicine (Baltimore); 2024 May; 103(21):e38303. PubMed ID: 38787969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lacrimal gland sparing IgG4-related disease in the orbit.
    Khan TT; Halat SK; Al Hariri AB
    Ocul Immunol Inflamm; 2013 Jun; 21(3):220-4. PubMed ID: 23480602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gastric relapse of stage I ocular adnexal mucosa-associated lymphoid tissue lymphoma].
    Sato T; Takimoto R; Iyama S; Ono K; Tanaka S; Araki N; Nishiie K; Murase K; Sato Y; Kobune M; Matsunaga T; Kato J; Niitsu Y
    Rinsho Ketsueki; 2007 Jan; 48(1):56-60. PubMed ID: 17313077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics, diagnosis and therapeutic strategies for IgG4-related orbital disease.
    Oles K; Sładzień J; Bartuś K; Leszczyńska J; Bojanowska E; Krakowczyk Ł; Mika J
    Pharmacol Rep; 2016 Jun; 68(3):507-13. PubMed ID: 27116895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A clinicopathological study of IgG4-related ocular disease and differentiated diagnosis with non-IgG4-related ocular disorders].
    Wu X; Luo QL; Li GD
    Zhonghua Yan Ke Za Zhi; 2016 Apr; 52(4):256-62. PubMed ID: 27094062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular adnexal IgG4-producing mucosa-associated lymphoid tissue lymphoma mimicking IgG4-related disease.
    Sato Y; Ohshima K; Takata K; Huang X; Cui W; Ohno K; Yoshino T
    J Clin Exp Hematop; 2012; 52(1):51-5. PubMed ID: 22706531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.